Semax
A synthetic neuropeptide analog often discussed for cognitive and neuroprotection-related interest in research-market circles.
Also appears in: Immune
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary lane: Nootropic. Also surfaces under Immune for browsing and discovery.
No major aliases are tracked for this profile yet.
No FDA label signal · 0 trials · 395 PubMed results
What semax is
Semax is a synthetic neuropeptide analog that appears in nootropic and neuroprotection conversations. It is often grouped near selank, but the two should not be treated as interchangeable.
Why it matters
This profile helps build out the cognitive side of the peptide library and makes the nootropic category feel intentional instead of token.
Regulatory context
Semax is not an FDA-approved cognitive or neurologic peptide medicine in the United States. It belongs to the research-market/nootropic side of peptide discussion.
Practical reading note
Readers should expect wide variation in claim quality here. Mechanistic interest and community demand do not automatically translate into strong clinical evidence.